Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-06

Clinical Trial Update: Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on using myo-inositol as pretreatment in hyperandrogenic PCOS patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Myo-inositol (myo-inositol)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: PCOS, Female Infertility | Phase 3 | Status: UNKNOWN